Paul J. Pockros

机构：Scripps Research Institute, Scripps Clinic · ORCID：0000-0001-9438-5893

发表论文 284 篇 · 总被引 21184 次 · h-index 65

代表论文

• Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial (2019 · The Lancet · 被引 1263)
• Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials (2020 · Journal of Hepatology · 被引 495)
• CONTROL: A randomized phase 2 study of obeticholic acid and atorvastatin on lipoproteins in nonalcoholic steatohepatitis patients (2019 · Liver International · 被引 161)
• Long-Term Obeticholic Acid Therapy Improves Histological Endpoints in Patients With Primary Biliary Cholangitis (2019 · Clinical Gastroenterology and Hepatology · 被引 105)
• A Randomized, Controlled, Phase 2 Study of Maralixibat in the Treatment of Itching Associated With Primary Biliary Cholangitis (2019 · Hepatology Communications · 被引 97)
• Morphometry Confirms Fibrosis Regression From Sustained Virologic Response to Direct‐Acting Antivirals for Hepatitis C (2018 · Hepatology Communications · 被引 70)